# ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)

> **NCT05894577** · PHASE3 · COMPLETED · sponsor: **Susanna Naggie, MD** · enrollment: 1453 (actual)

## Conditions studied

- Covid19

## Interventions

- **OTHER:** Placebo
- **DRUG:** Montelukast

## Key facts

- **NCT ID:** NCT05894577
- **Lead sponsor:** Susanna Naggie, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-27
- **Primary completion:** 2023-07-31
- **Final completion:** 2024-01-01
- **Target enrollment:** 1453 (ACTUAL)
- **Last updated:** 2025-01-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05894577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05894577, "ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05894577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*